These composite biomarkers show promise for risk stratification, particularly for PCa, where PSA and multiparametric magnetic resonance imaging (mpMRI) have limitations, especially in the PSA “gray zone”. The gene discussed is KLK3; the disease is posterior cortical atrophy.